Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$10.31 USD
+0.03 (0.29%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $10.30 -0.01 (-0.10%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Amicus Therapeutics, Inc. [FOLD]
Reports for Purchase
Showing records 141 - 160 ( 176 total )
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Downgrading to UNDERPERFORM from NEUTRAL, Fabry Phase III Study Fails, Lowering Price Target to $1.50
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q3:12 EPS, Key Results for Migalastat Monotherapy Coming Q4:12, Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
We are initiating coverage with Buy rating and $7 price target
Provider: CAPSTONE INVESTMENTS
Analyst: GANDHI M
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
September 2012 Potential Catalysts & Milestones - Monthly Update
Provider: WEDBUSH SECURITIES INC.
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of September 2, 2012
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q2:12 EPS, Key Phase III Monotherapy Migalastat Data Now in Q4:12 to Accommodate FDA, Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of August
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of July 29
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Lowering Price Target,Updating and Correcting Financial Model After Restructured Partnership with GSK, Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Restructured GSK Partnership and Equity Investment Give Amicus US Commercial Rights, Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
July 2012 Potential Catalysts & Milestones - Monthly Update
Provider: WEDBUSH SECURITIES INC.
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
June 2012 Potential Catalysts & Milestones - Monthly Update
Provider: WEDBUSH SECURITIES INC.
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences - Upcoming Events for the Week of June 3
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q1:12 EPS, Key Phase II and Phase III Migalastat Data Likely in Q3:12, Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Q4:11 Earnings a Non-Event, Data Presented at Rare Disease Conference, Reiterate NEUTRAL
Provider: WEDBUSH SECURITIES INC.
Analyst: WADE G
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Semiconductor Industry Association (SIA) December Data: Revenue Increases M/M
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Amicus Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
February 2012 Potential Catalysts & Milestones - Monthly Update
Provider: WEDBUSH SECURITIES INC.